Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prohibitin pseudogene 6 (PHB1P6) is a processed human pseudogene, mapped to chromosome 7 (chr7:75203926-75204711, hg38). It is classified as a pseudogene because it originated from the duplication or retrotransposition of the PHB1 (prohibitin) gene and has lost the ability to code a functional protein. Pseudogenes of this class, in general, can sometimes regulate gene expression post-transcriptionally by acting as miRNA decoys or through involvement in generation of siRNAs, but there is currently no evidence directly linking PHB1P6 to such regulatory function, disease mechanisms, or therapeutic relevance. No drugs, biomarkers, or safety issues are associated with this pseudogene, and it is not considered a molecular target or functional receptor, enzyme, or transporter.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prohibitin pseudogene 6 (PHB1P6).